Nicola Davis: There's already a lot of pressure on people who are obese to lose weight. She says that can lead to issues around body imaging disorders. And she also raises an important point about the need for psychological and lifestyle support where these drugs are used, which needs to be considered as well. The availability of these drugs creates an atmosphere in which people with BMI over 35 over 30 might feel pressured to be taking them.
Ian Sample speaks to Guardian science correspondent Nicola Davis about the news that Wegovy, an appetite suppressant popular with celebrities in the US, will soon be sold at UK pharmacies. It’s a prescription drug aimed at helping people with obesity lose weight, but some argue it doesn’t tackle the root cause of the disease. Help support our independent journalism at
theguardian.com/sciencepod